The mission of the TRAC is to pool the expertise and resources of an outstanding team of senior tuberculosis (TB) investigators at the three institutions in order to expand the number of investigators in the field of TB research and to promote innovative multidisciplinary TB research.
We are proud to share that Dr. Jyoti Mathad, a faculty member at our NYC-TRAC, has played a leading role in a new global initiative by the World Health Organization (WHO) to address inequities in tuberculosis (TB) research for pregnant and lactating women. Over the past two years, Dr. Mathad has co-led the Therapeutics Working Group of the WHO consensus team, helping to develop critical recommendations that place pregnant and lactating women at the forefront of TB therapeutics research.
Our center is now accepting applications for the NYC-TRAC Developmental Award. This program supports early-stage and established investigators with high-impact ideas aimed at advancing tuberculosis research, prevention, and treatment.
Letter of Intent (required) August 15, 2025
Full Application (by invitation) September, 2025
Purpose: Seed funding for innovative TB research projects that can evolve into full-scale grants or clinical studies.
Effective July 1, Dr. Sabine Ehrt— Basic Science Core Director of NYC TRAC—will become chair of the Department of Microbiology and Immunology at Weill Cornell Medicine. Dr. Ehrt plans to build on the Department’s strong TB program, recruit faculty in antimicrobial resistance and malaria, and foster collaborations with the Cornell Center for Antimicrobial Resistance Research and the College of Veterinary Medicine. She also aims to expand mentoring for junior scientists.
We are excited to share a report on the recent 9th Annual Tuberculosis Symposium “The Future of TB Research” held on April 24, 2025, at the University of Washington in Seattle.
